Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hoflack

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Therapie|November 1, 1991
[Modeling of hormonal receptors. Application to drug design]M F Hibert, S Trumpp-Kallmeyer, A T Bruinvels, et al.
Drug Design and Discovery|June 1, 1993
Three-dimensional models of gonado-thyrotropin hormone receptor transmembrane domainJ Hoflack, M F Hibert, S Trumpp-Kallmeyer, et al.
Journal of Protein Chemistry|February 1, 1994
Contribution of unusual arginine-arginine short-range interactions to stabilization and recognition in proteinsA Magalhaes, B Maigret, J Hoflack, et al.
Pharmaceutica Acta Helvetiae|September 1, 1995
Towards understanding the role of the first extracellular loop for the binding of peptide hormones to G-protein coupled receptorsS Trumpp-Kallmeyer, B Chini, B Mouillac, et al.
Journal of Computer-Aided Molecular Design|July 1, 1997
Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinementH Bourdon, S Trumpp-Kallmeyer, H Schreuder, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
Inhibition of myo-inositol monophosphatase isoforms by aromatic phosphonatesA J Ganzhorn, J Hoflack, P D Pelton, et al.
The Journal of Biological Chemistry|October 27, 1995
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regionsB Mouillac, B Chini, M N Balestre, et al.
Journal of Receptor and Signal Transduction Research|March 11, 1999
Functional architecture of vasopressin/oxytocin receptorsM Hibert, J Hoflack, S Trumpp-Kallmeyer, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Identification of agonist binding sites of vasopressin and oxytocin receptorsB Mouillac, B Chini, M N Balestre, et al.
The EMBO Journal|May 15, 1995
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptorB Chini, B Mouillac, Y Ala, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Therapie|November 1, 1991
[Modeling of hormonal receptors. Application to drug design]M F Hibert, S Trumpp-Kallmeyer, A T Bruinvels, et al.
Drug Design and Discovery|June 1, 1993
Three-dimensional models of gonado-thyrotropin hormone receptor transmembrane domainJ Hoflack, M F Hibert, S Trumpp-Kallmeyer, et al.
Journal of Protein Chemistry|February 1, 1994
Contribution of unusual arginine-arginine short-range interactions to stabilization and recognition in proteinsA Magalhaes, B Maigret, J Hoflack, et al.
Pharmaceutica Acta Helvetiae|September 1, 1995
Towards understanding the role of the first extracellular loop for the binding of peptide hormones to G-protein coupled receptorsS Trumpp-Kallmeyer, B Chini, B Mouillac, et al.
Journal of Computer-Aided Molecular Design|July 1, 1997
Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinementH Bourdon, S Trumpp-Kallmeyer, H Schreuder, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
Inhibition of myo-inositol monophosphatase isoforms by aromatic phosphonatesA J Ganzhorn, J Hoflack, P D Pelton, et al.
The Journal of Biological Chemistry|October 27, 1995
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regionsB Mouillac, B Chini, M N Balestre, et al.
Journal of Receptor and Signal Transduction Research|March 11, 1999
Functional architecture of vasopressin/oxytocin receptorsM Hibert, J Hoflack, S Trumpp-Kallmeyer, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Identification of agonist binding sites of vasopressin and oxytocin receptorsB Mouillac, B Chini, M N Balestre, et al.
The EMBO Journal|May 15, 1995
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptorB Chini, B Mouillac, Y Ala, et al.
Pageof 3